Touting its novel approach for treating glaucoma, Qlaris Bio Inc. reported promising top-line data from two phase II studies testing QLS-111 in patients with primary open-angle glaucoma and ocular ...

Bristol Myers Squibb's Breyanzi showed strong efficacy in Phase 2 lymphoma trial, meeting key endpoints. FDA approvals expand its reach in B-cell cancers.

The Massachusetts Bay Transportation Authority will launch South Coast Rail operations — serving a group of southeastern ...

Detailed price information for Tempest Therapeutics Inc (TPST-Q) from The Globe and Mail including charting and trades.

A class action lawsuit was filed against Cassava Sciences Inc. (SAVA) by Levi & Korsinsky on December 12, 2024. The ...

After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

The ACP guideline, published in Annals of Internal Medicine, includes three recommendations centered around monotherapy: ...

WoFi is an instant, no-frills sonic mangler, which is ridiculously easy to use and yields incredibly dramatic results. It's ...

During a Case-Based Roundtable® event, Nakhle Saba, MD, and participants discussed the data supporting the 2 newer BTK ...

New blinded preliminary BRTX-100 data described this past Saturday at prestigious “2025 Winners in Industry Innovations in MSK Health” ...

The new stadium network will serve as a central hub for an expansion of Wi-Fi 6E across the campus, providing high-speed ...